Showing results (1-10 of 342) with videos related to
Sort By:
Pageof 35
Immunotherapy|April 6, 2013
Bortezomib for the treatment of previously untreated multiple myelomaAlessandra Romano, Concetta Conticello, Francesco Di RaimondoExpert Review of Anticancer Therapy|September 28, 2020
On the road to treatment-free remission in chronic myeloid leukemia: what about 'the others'?Fabio Stagno, Massimo Breccia, Francesco Di RaimondoFrontiers in Oncology|November 12, 2019
Management of Chronic Myeloid Leukemia in Advanced PhaseMassimiliano Bonifacio, Fabio Stagno, Luigi Scaffidi, et al.Hematology Reports|October 12, 2020
How we manage smoldering multiple myelomaAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.International Surgery|July 30, 2002
Lymphoma of the cecum: a case reportAntonio Di Cataldo, Raffaele Lanteri, Cristian Rapisarda, et al.Cancer Reports (Hoboken, N.J.)|August 9, 2023
AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinibAndrea Duminuco, Adrian Mosquera-Orgueira, Antonella Nardo, et al.Haematologica|August 6, 2002
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myelomaRoberto Ria, Angelo Vacca, Domenico Ribatti, et al.Expert Review of Anticancer Therapy|February 9, 2016
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomesFabio Stagno, Stefania Stella, Antonio Spitaleri, et al.Journal of Medical Case Reports|November 9, 2016
Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case reportGaetano Giuffrida, Rita Lombardo, Ernesto Di Francesco, et al.Cancer Diagnosis & Prognosis|April 11, 2022
A Treatment-free Interval Allowed by Ponatinib as Fourth-line TherapyAnna Bulla, Uros Markovic, Claudia Bellofiore, et al.Pageof 35